X0508 4 2025-11-15 false 0001817241 Artiva Biotherapeutics, Inc. ARTV 0001909362 Aslan Fred C/O ARTIVA BIOTHERAPEUTICS, INC. 5505 MOREHOUSE DRIVE, SUITE 100 SAN DIEGO CA 92121 true true false false President and CEO true Common Stock 2025-11-15 4 F false 6347 3.25 D 350374 D Common Stock 2025-11-17 4 S false 6375 3.376 D 343999 D Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of restricted stock unit awards. The reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on July 23, 2024. The weighted average sale price for the transaction reported was $3.376, and the range of prices were between $3.19 and $3.53. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. /s/ Neha Krishnamohan, Attorney-in-Fact 2025-11-17